Cocoon platform. If you need full customization, we can work with you to tailor it to your unique process. The Cocoon Platform (Lonza, Basel, Switzerland) addresses many challenges, such as high labor demand, process consistency, contamination risks and scalability, by enabling efficient, functionally closed and automated production, whether at clinical or commercial scale. Cocoon simplifies employee leave management by automating compliance, claims, and payroll processes for People teams and employees. The Cocoon® Platform is a functionally closed, automated system designed to simplify and scale cell therapy manufacturing. Combined with Akadeum’s GMP-grade Human T Cell Leukopak Isolation Kit, the Cocoon® Platform enables automated microbubble-based T cell enrichment directly from cryopreserved leukopaks, without the need for additional The Cocoon® Platform is a viable solution to translate labor-intensive cell therapy processes to an automated system allowing scalability, high yield, reduction of manufacturing cost, minimizing operator error, and improved process control. Benefits of the Cocoon® Platform Efficient end-to-end automation The Cocoon® system seamlessly integrates multiple steps, including upstream and downstream processing, for a complete cell processing solution. It drives down costs, provides greater access to patients and delivers a higher quality product. Related Cells: Categories: Why the Cocoon® Platform? Efficient and highly tailored cell therapy manufacturing platform Highly customizable and scalable, the Cocoon® Platform is a ready to use integrated turnkey solution. Download our brochure to learn about the Cocoon® Platform Brochure, an automated, functionally closed, and flexible solution for cell therapy manufacturing. This brochure provide you with an overview of Cocoon® Platform Brochure environmental unit, customizable cassette, and user-friendly software, as well as our commitment to regulatory and quality excellence.
mjorqt hqikaav uqyok ddfn lkumm jiqyif tgmoabv adha vcjp muopsuv